Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease

Parkinson's disease (PD) is the second commonest progressive neurodegenerative disease worldwide. Increasing evidence reveals that non-coding RNAs play roles in the pathophysiological process of PD. The notion called competing endogenous RNAs (ceRNAs) network is used to describe the roles of no...

Full description

Bibliographic Details
Main Authors: Xi Zhang, Shengyu Feng, Yu Fan, Yuping Luo, Lingjing Jin, Siguang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fneur.2020.00810/full
_version_ 1818265805540818944
author Xi Zhang
Xi Zhang
Shengyu Feng
Yu Fan
Yuping Luo
Lingjing Jin
Siguang Li
Siguang Li
Siguang Li
author_facet Xi Zhang
Xi Zhang
Shengyu Feng
Yu Fan
Yuping Luo
Lingjing Jin
Siguang Li
Siguang Li
Siguang Li
author_sort Xi Zhang
collection DOAJ
description Parkinson's disease (PD) is the second commonest progressive neurodegenerative disease worldwide. Increasing evidence reveals that non-coding RNAs play roles in the pathophysiological process of PD. The notion called competing endogenous RNAs (ceRNAs) network is used to describe the roles of non-coding RNAs. According to this theory, long non-coding RNAs (lncRNAs) act as microRNAs (miRNAs) sponges by miRNA response elements or miRNA binding sites to control the availability of endogenous miRNA for binding to their target mRNAs. This study aimed to construct a ceRNA network in PD, which might have the potential to clarify the pathogenesis of PD. We investigated differential expression (DE) lncRNAs and mRNAs in substantia nigra array data GSE7621 between PD patients and healthy controls from the Gene Expression Omnibus database. And we used starBase 2.0 and miRWalk 2.0 databases to predict miRNAs that have interactions with DElncRNAs and DEmRNAs. Based on DElncRNAs, DEmRNAs and predicted miRNAs, two ceRNA networks were constructed. The first one was based on lncRNA-miRNA interactions and miRNA-mRNA interactions that shared the same miRNAs that we predicted, on which function annotation and PPI analysis were performed to identify hub genes. Hereby the second ceRNA network was generated to explore the core section in the first ceRNA network and was validated in external datasets. As a result, we identified 31 DE lncRNAs and 1,828 DEmRNAs, and finally constructed the first ceRNA network associated with PD, including 9 lncRNAs, 18 miRNAs, and 185 mRNAs. mRNAs in the first ceRNA network focused on autophagy, DNA repair and vesicle transport, which were critical pathological processes in PD. Nineteen hub genes in the first ceRNA network identified through PPI analysis, the second ceRNA network was constructed to annotate the core part of the first one. Moreover, the core subnetwork was validated in external datasets, of which several nodes including FBXL7, PTBP2, and lncRNA NEAT1 were verified. In conclusion, a ceRNA network was constructed based on the differential expression profiles of whole substantia nigra tissues of normal and PD patients, and the network was subsequently identified which revealed its association with autophagy, DNA repair and vesicle transport. The core subnetwork of the ceRNA network was identified and validated in external data. Our findings offered novel insights into the roles of ceRNAs in the pathogenesis of PD and provided promising diagnostic biomarkers.
first_indexed 2024-12-12T19:56:39Z
format Article
id doaj.art-98bb97ab55e344e38cf60f108a648868
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-12T19:56:39Z
publishDate 2020-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-98bb97ab55e344e38cf60f108a6488682022-12-22T00:13:52ZengFrontiers Media S.A.Frontiers in Neurology1664-22952020-08-011110.3389/fneur.2020.00810553509Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's DiseaseXi Zhang0Xi Zhang1Shengyu Feng2Yu Fan3Yuping Luo4Lingjing Jin5Siguang Li6Siguang Li7Siguang Li8Stem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Neurology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaStem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaStem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaStem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Neurology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaStem Cell Translational Research Center, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaDepartment of Neurology, Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaKey Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Orthopedic Department of Tongji Hospital, Tongji University School of Medicine, Shanghai, ChinaParkinson's disease (PD) is the second commonest progressive neurodegenerative disease worldwide. Increasing evidence reveals that non-coding RNAs play roles in the pathophysiological process of PD. The notion called competing endogenous RNAs (ceRNAs) network is used to describe the roles of non-coding RNAs. According to this theory, long non-coding RNAs (lncRNAs) act as microRNAs (miRNAs) sponges by miRNA response elements or miRNA binding sites to control the availability of endogenous miRNA for binding to their target mRNAs. This study aimed to construct a ceRNA network in PD, which might have the potential to clarify the pathogenesis of PD. We investigated differential expression (DE) lncRNAs and mRNAs in substantia nigra array data GSE7621 between PD patients and healthy controls from the Gene Expression Omnibus database. And we used starBase 2.0 and miRWalk 2.0 databases to predict miRNAs that have interactions with DElncRNAs and DEmRNAs. Based on DElncRNAs, DEmRNAs and predicted miRNAs, two ceRNA networks were constructed. The first one was based on lncRNA-miRNA interactions and miRNA-mRNA interactions that shared the same miRNAs that we predicted, on which function annotation and PPI analysis were performed to identify hub genes. Hereby the second ceRNA network was generated to explore the core section in the first ceRNA network and was validated in external datasets. As a result, we identified 31 DE lncRNAs and 1,828 DEmRNAs, and finally constructed the first ceRNA network associated with PD, including 9 lncRNAs, 18 miRNAs, and 185 mRNAs. mRNAs in the first ceRNA network focused on autophagy, DNA repair and vesicle transport, which were critical pathological processes in PD. Nineteen hub genes in the first ceRNA network identified through PPI analysis, the second ceRNA network was constructed to annotate the core part of the first one. Moreover, the core subnetwork was validated in external datasets, of which several nodes including FBXL7, PTBP2, and lncRNA NEAT1 were verified. In conclusion, a ceRNA network was constructed based on the differential expression profiles of whole substantia nigra tissues of normal and PD patients, and the network was subsequently identified which revealed its association with autophagy, DNA repair and vesicle transport. The core subnetwork of the ceRNA network was identified and validated in external data. Our findings offered novel insights into the roles of ceRNAs in the pathogenesis of PD and provided promising diagnostic biomarkers.https://www.frontiersin.org/article/10.3389/fneur.2020.00810/fullParkinson's disease (PD)competitive endogenous RNAsceRNA networkpathogenesislong non-coding RNAs (lncRNAs)
spellingShingle Xi Zhang
Xi Zhang
Shengyu Feng
Yu Fan
Yuping Luo
Lingjing Jin
Siguang Li
Siguang Li
Siguang Li
Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease
Frontiers in Neurology
Parkinson's disease (PD)
competitive endogenous RNAs
ceRNA network
pathogenesis
long non-coding RNAs (lncRNAs)
title Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease
title_full Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease
title_fullStr Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease
title_full_unstemmed Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease
title_short Identifying a Comprehensive ceRNA Network to Reveal Novel Targets for the Pathogenesis of Parkinson's Disease
title_sort identifying a comprehensive cerna network to reveal novel targets for the pathogenesis of parkinson s disease
topic Parkinson's disease (PD)
competitive endogenous RNAs
ceRNA network
pathogenesis
long non-coding RNAs (lncRNAs)
url https://www.frontiersin.org/article/10.3389/fneur.2020.00810/full
work_keys_str_mv AT xizhang identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT xizhang identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT shengyufeng identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT yufan identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT yupingluo identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT lingjingjin identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT siguangli identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT siguangli identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease
AT siguangli identifyingacomprehensivecernanetworktorevealnoveltargetsforthepathogenesisofparkinsonsdisease